Breast cancer clinical trials: current issues and possible solutions

Abstract

George Dranitsaris speaks to Alisa Crisp, Commissioning Editor: George Dranitsaris is a health services research consultant with graduate training in biostatistics, pharmacoeconomics, decision analysis and clinical epidemiology. His areas of interest include comparative effectiveness analysis, the measurement of cost-effective drug use in the oncology setting, value-based drug pricing and the evaluation of drug performance outside the trial setting. He has over 100 publications in the national and international literature, is past President of the Canadian Association of Pharmacy in Oncology, a statistical reviewer for the Journal of Clinical Oncology and a member of the editorial board of the Journal of Oncology Pharmacy Practice and the European Journal of Hospital Pharmacy Science.